fibrinogen has been researched along with Prediabetic State in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Q; Dong, QT; Gao, Y; Guo, YL; Li, JJ; Liu, SL; Shi, HW; Wu, NQ | 1 |
| Gao, R; Gao, Z; Jia, S; Jiang, P; Liu, R; Liu, Y; Tang, X; Xu, B; Xu, J; Yang, Y; Yuan, D; Yuan, J; Zhang, C; Zhao, X; Zhu, P | 1 |
| Gdula-Dymek, A; Krysiak, R; Okopień, B | 1 |
| Arturi, F; Fiorentino, TV; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G; Succurro, E | 1 |
| Aguilar-Sosa, E; Anaya-Gómez, F; Galván-Plata, ME; Isordia-Salas, I; Leaños-Miranda, A; Majluf-Cruz, A; Santiago-Germán, D | 1 |
| Andreozzi, F; Fiorentino, TV; Hribal, ML; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G | 1 |
| Bardini, G; Cresci, B; Dicembrini, I; Rotella, CM | 1 |
| Bachowski, R; Gdula-Dymek, A; Krysiak, R; Okopien, B | 1 |
| Krysiak, R; Okopien, B | 1 |
| Festa, A; Goodarzi, MO; Haffner, SM; Hanley, AJ; Lee, CC; Lorenzo, C; Norris, JM; Olson, NC; Rewers, MJ; Stefanovski, D; Wagenknecht, LE | 1 |
| D'Agostino, R; Festa, A; Haffner, SM; Hanley, AJ; Tracy, RP | 1 |
| Angeloni, SV; Hansen, BC; Selaru, IK; Tigno, XT | 1 |
| Avcu, F; Dogru, T; Erdem, G; Erikci, S; Genc, H; Kilic, S; Savasci, S; Sonmez, A; Tasci, I; Ural, AU | 1 |
| Acevedo, M; Cross, JA; Foody, JM; Frolkis, JP; Hoogwerf, BJ; Pashkow, FJ; Pearce, GL; Robinson, K; Sprecher, DL; Vidt, DG | 1 |
3 trial(s) available for fibrinogen and Prediabetic State
| Article | Year |
|---|---|
Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance.
Topics: Dose-Response Relationship, Drug; Drug Synergism; Female; Fenofibrate; Fibrinogen; Glucose Intolerance; Hemostasis; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Prediabetic State; Single-Blind Method | 2013 |
Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.
Topics: Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Cytokines; Factor VII; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Metabolic Syndrome; Plasminogen Activator Inhibitor 1; Prediabetic State; Pyrroles | 2010 |
Haemostatic effects of metformin in simvastatin-treated volunteers with impaired fasting glucose.
Topics: Antigens; Blood Coagulation; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Factor VII; Fasting; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Prediabetic State; Simvastatin | 2012 |
11 other study(ies) available for fibrinogen and Prediabetic State
| Article | Year |
|---|---|
Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Topics: Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Myocardial Revascularization; Prediabetic State; Progression-Free Survival; Risk Assessment; Risk Factors; Time Factors; Up-Regulation | 2020 |
Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
Topics: Aged; Biomarkers; Blood Glucose; Cause of Death; Coronary Artery Disease; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prediabetic State; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile.
Topics: Adult; Aged; Asymptomatic Diseases; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Complement C3; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Inflammation; Male; Metabolome; Middle Aged; Prediabetic State; Risk Factors; Time Factors | 2014 |
Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease.
Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Early Diagnosis; Female; Fibrinogen; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mexico; Middle Aged; Overweight; Prediabetic State; Risk Factors; Thrombosis; Vasculitis | 2014 |
Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria.
Topics: Adult; Aged; American Medical Association; Association; Biomarkers; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Complement C3; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Prediabetic State; United States | 2015 |
Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels.
Topics: Adult; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Inflammation; Leukocyte Count; Male; Middle Aged; Prediabetic State; Triglycerides; Waist Circumference; Young Adult | 2010 |
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).
Topics: Atherosclerosis; Body Mass Index; Cohort Studies; Diabetic Angiopathies; Female; Fibrinogen; Follow-Up Studies; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Leptin; Male; Metabolic Clearance Rate; Middle Aged; Overweight; Plasminogen Activator Inhibitor 1; Prediabetic State; Prospective Studies; Risk Factors; United States | 2013 |
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
Topics: Adipose Tissue; Arteriosclerosis; Body Composition; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Humans; Incidence; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prediabetic State; Risk Factors | 2003 |
Is microvascular flow rate related to ghrelin, leptin and adiponectin levels?
Topics: Adiponectin; Animals; Blood Glucose; Fibrinogen; Ghrelin; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Hypolipidemic Agents; Intercellular Signaling Peptides and Proteins; Leptin; Macaca mulatta; Metabolic Syndrome; Microcirculation; Obesity; Peptide Hormones; Prediabetic State; Proteins | 2003 |
Platelet aggregation is not enhanced in patients with prediabetes.
Topics: Adult; Case-Control Studies; Female; Fibrinogen; Glucose Tolerance Test; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Platelet Aggregation; Prediabetic State | 2007 |
Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk.
Topics: Adult; Aged; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Prediabetic State; Risk Factors | 2002 |